Patients on combination therapy had worse glycemic outcomes, which may be indicative of more advanced disease or greater insulin resistance The finding that patients receiving both oral medications and insulin had significantly poorer glycemic control may indicate a more advanced disease stage or higher insulin resistance, necessitating more aggressive management strategies. The gene discussed is INS; the disease is Insulin resistance.